HSC Section 3 - Trauma, Critical Care and Sleep Medicine

O

58. Benoit MM, North PE, McKenna MJ, et al. Facial nerve hemangiomas: vascular tumors or malformations? Otolaryngol Head Neck Surg 2010;142(1):108–14 . 59. Oldenburg MS, Carlson ML, Van Abel KM, et al. Management of geniculate gan- glion hemangiomas: case series and systematic review of the literature. Otol Neu- rotol 2015;36(10):1735–40 . 60. Han SJ, Englot DJ, Kim H, et al. Brainstem arteriovenous malformations: anatom- ical subtypes, assessment of “occlusion in situ” technique, and microsurgical re- sults. J Neurosurg 2015;122(1):107–17 . 61. Stein KP, Wanke I, Schlamann M, et al. Posterior fossa arterio-venous malforma- tions: current multimodal treatment strategies and results. Neurosurg Rev 2014; 37(4):619–28 . 62. Alrashdi IS, Rich P, Patton MA. A family with hereditary congenital facial paresis and a brief review of the literature. Clin Dysmorphol 2010;19(4):198–201 . 63. Cha CI, Hong CK, Park MS, et al. Comparison of facial nerve paralysis in adults and children. Yonsei Med J 2008;49(5):725–34 . 64. Gaudin RA, Jowett N, Banks CA, et al. Bilateral facial paralysis: a 13-year expe- rience. Plast Reconstr Surg 2016;138(4):879–87 . 65. Sherwen PJ, Thong NC. Bilateral facial nerve palsy: a case study and literature review. J Otolaryngol 1987;16(1):28–33 . 66. Oosterveer DM, Benit CP, de Schryver EL. Differential diagnosis of recurrent or bilateral peripheral facial palsy. J Laryngol Otol 2012;126(8):833–6 . 67. Madhok VB, Gagyor I, Daly F, et al. Corticosteroids for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2016;(7):CD001942 . 68. Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med 2007;357(16):1598–607 . 69. Engstrom M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2008;7(11):993–1000 . 70. Austin JR, Peskind SP, Austin SG, et al. Idiopathic facial nerve paralysis: a ran- domized double blind controlled study of placebo versus prednisone. Laryngo- scope 1993;103(12):1326–33 . 71. Unuvar E, Oguz F, Sidal M, et al. Corticosteroid treatment of childhood Bell’s palsy. Pediatr Neurol 1999;21(5):814–6 . 72. Pitaro J, Waissbluth S, Daniel SJ. Do children with Bell’s palsy benefit from steroid treatment? A systematic review. Int J Pediatr Otorhinolaryngol 2012;76(7):921–6 . 73. Lagalla G, Logullo F, Di Bella P, et al. Influence of early high-dose steroid treat- ment on Bell’s palsy evolution. Neurol Sci 2002;23(3):107–12 . 74. Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell’s palsy. Oto- laryngol Head Neck Surg 2013;149(3 Suppl):S1–27 . 75. Miller CS, Cunningham LL, Lindroth JE, et al. The efficacy of valacyclovir in pre- venting recurrent herpes simplex virus infections associated with dental proced- ures. J Am Dent Assoc 2004;135(9):1311–8 . 76. Miller CS, Avdiushko SA, Kryscio RJ, et al. Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. J Clin Microbiol 2005;43(5):2173–80 . 77. Gilbert S, McBurney E. Use of valacyclovir for herpes simplex virus-1 (HSV-1) prophylaxis after facial resurfacing: a randomized clinical trial of dosing regi- mens. Dermatol Surg 2000;26(1):50–4 . 78. Hato N, Yamada H, Kohno H, et al. Valacyclovir and prednisolone treatment for Bell’s palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 2007;28(3):408–13 .

65